Effects of p21^Cip1/Waf1 at Both the G₁/S and the G₂/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication

REFERENCES

• Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92: 8493–8497.
   PubMed Web of Science ®Google Scholar
• Beamish, H., R. Williams, P. Chen, and M. F. Lavin 1996. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271: 20486–20493.
   PubMed Web of Science ®Google Scholar
• Blasina, A., E. S. Paegle, and C. H. McGowan 1997. The role of inhibitory phosphorylation of cdc2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell 8: 1013–1023.
   PubMedGoogle Scholar
• Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557.
   PubMed Web of Science ®Google Scholar
• Cardoso, M., H. Leonhardt, and B. Nadal-Ginard 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74: 979–992.
   PubMedGoogle Scholar
• Chen, X., L. J. Ko, L. Jayaraman, and C. Prives 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10: 2438–2451.
   PubMed Web of Science ®Google Scholar
• Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272: 719–722.
   PubMed Web of Science ®Google Scholar
• Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine, and J. M. Roberts 1996. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10: 1979–1990.
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo, C. 1995. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J. Pathol. 147: 545–560.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545–5549.
   PubMed Web of Science ®Google Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
   PubMed Web of Science ®Google Scholar
• Diatloff-Zito, C., C. Turleau, M. O. Cabanis, and J. de Grouchy 1984. Low dose rate ionizing radiation induces increased growth capacities of d-deletion retinoblastoma skin fibroblasts. Carcinogenesis 5: 1305–1310.
   PubMedGoogle Scholar
• Dulic, V., E. Lees, and S. I. Reed 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958–1961.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013–23.
   PubMed Web of Science ®Google Scholar
• Dulic, V., G. H. Stein, D. F. Far, and S. I. Reed 1998. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role in the G2/M-phase transition? Mol. Cell. Biol. 18: 546–557.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W., J. W. Harper, P. M. O’Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169–1174.
   PubMed Web of Science ®Google Scholar
• Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664–1672.
   PubMed Web of Science ®Google Scholar
• Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499–502.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733–744.
   PubMed Web of Science ®Google Scholar
• Gallant, P., A. M. Fry, and E. A. Nigg 1995. Protein kinases in the control of mitosis: focus on nucleocytoplasmic trafficking. J. Cell Sci. Suppl. 19: 21–28.
   PubMedGoogle Scholar
• Gallie, B. L. 1994. Retinoblastoma gene mutations in human cancer. N. Engl. J. Med. 330: 786–787.
   PubMed Web of Science ®Google Scholar
• Girard, F., U. Strausfeld, A. Fernandez, and N. J. Lamb 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169–1179.
   PubMed Web of Science ®Google Scholar
• Guadagno, T. M., and J. W. Newport 1996. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84: 73–82.
   PubMedGoogle Scholar
• Guan, K. L., C. W. Jenkins, Y. Li, M. A. Nichols, X. Wu, C. L. O’Keefe, A. G. Matera, and Y. Xiong 1994. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8: 2939–2952.
   PubMed Web of Science ®Google Scholar
• Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021.
   PubMed Web of Science ®Google Scholar
• Hannon, G., and D. Beach 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257–261.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, C. L. Connell, E. Swindell, M. P. Fox, and N. Wei 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6: 387–400.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and S. J. Elledge 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56–64.
   PubMed Web of Science ®Google Scholar
• Hawkins, M. M., L. M. Wilson, H. S. Burton, M. H. Potok, D. L. Winter, H. B. Marsden, and M. A. Stovall 1996. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J. Natl. Cancer Inst. 88: 270–278.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91: 5291–5295.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and S. I. Reed 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861–1864.
   PubMed Web of Science ®Google Scholar
• Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Makela, R. A. Weinberg, and T. Jacks 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16: 2402–2407.
   PubMedGoogle Scholar
• Hirai, H., M. F. Roussel, J. Y. Kato, R. A. Ashmun, and C. J. Sherr 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15: 2672–2681.
   PubMed Web of Science ®Google Scholar
• Jacks, T. Personal communication.
   Google Scholar
• Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. P. Pavletich 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313–320.
   PubMed Web of Science ®Google Scholar
• Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF1/CIP1 expression in the absence of p53. Oncogene 9: 3397–3406.
   PubMed Web of Science ®Google Scholar
• Jiang, H., J. Lin, Z. Z. Su, M. Herlyn, R. S. Kerbel, B. E. Weissman, D. R. Welch, and P. B. Fisher 1995. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10: 1855–1864.
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., R. D. Kineman, T. K. Manova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85: 721–732.
   PubMed Web of Science ®Google Scholar
• Koyama, H., E. W. Raines, K. E. Bornfeldt, J. M. Roberts, and R. Ross 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87: 1069–1078.
   PubMed Web of Science ®Google Scholar
• Lee, M. H., I. Reynisdottir, and J. Massague 1995. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9: 639–649.
   PubMed Web of Science ®Google Scholar
• Lukas, J., J. Bartkova, M. Rohde, M. Strauss, and J. Bartek 1995. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15: 2600–2611.
   PubMed Web of Science ®Google Scholar
• MacLeod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9: 935–944.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9: 650–662.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066–2076.
   PubMed Web of Science ®Google Scholar
• Megyesi, J., N. Udvarhelyi, R. L. Safirstein, and P. M. Price 1996. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am. J. Physiol. 271: F1211–F1216.
   PubMedGoogle Scholar
• Missero, C., E. Calautti, R. Ekner, J. Chin, L.-H. Tsai, D. M. Livingston, and G. P. Dotto 1995. Involvement of the cell cycle inhibitor Cip1/WAF1 and the E1a-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92: 5451–5455.
   PubMed Web of Science ®Google Scholar
• Missero, C., F. Di Cunto, H. Kiyokawa, A. Koff, and G. P. Dotto 1996. The absence of p21Cip1/Waf1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10: 3065–3075.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374: 131–134.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. Nakayama 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707–720.
   PubMed Web of Science ®Google Scholar
• Nelson, W. G., and M. B. Kastan 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14: 1815–1823.
   PubMed Web of Science ®Google Scholar
• Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471–480.
   PubMed Web of Science ®Google Scholar
• Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90–98.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135: 441–456.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15: 2612–2624.
   PubMed Web of Science ®Google Scholar
• Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11: 961–971.
   PubMed Web of Science ®Google Scholar
• Parry, D., S. Bates, D. J. Mann, and G. Peters 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product. EMBO J. 14: 503–511.
   PubMed Web of Science ®Google Scholar
• Pines, J. 1995. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308: 697–711.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8: 9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. H. Lee, B. H. Erdjument, A. Koff, J. M. Roberts, P. Tempst, and J. Massague 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66.
   PubMed Web of Science ®Google Scholar
• Reed, S. I. 1996. Cyclin E: in mid-cycle. Biochim. Biophys. Acta 1287: 151–153.
   PubMedGoogle Scholar
• Resnitzky, D., M. Gossen, H. Bujard, and S. I. Reed 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669–1679.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., and J. Massague 1997. The subcellular location of p15INK4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11: 492–503.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massague, and N. P. Pavletich 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325–331.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., P. D. Jeffrey, and N. P. Pavletich 1996. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3: 696–700.
   PubMedGoogle Scholar
• Schwarz, J. K., C. H. Bassing, I. Kovesdi, M. B. Datto, M. Blazing, S. George, X. F. Wang, and J. R. Nevins 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92: 483–487.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1163.
   PubMed Web of Science ®Google Scholar
• Slebos, R. J., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M. B. Kastan, and K. R. Cho 1994. p53-dependent G1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91: 5320–5324.
   PubMed Web of Science ®Google Scholar
• Slingerland, J. M., L. Hengst, C. H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 14: 3683–3694.
   PubMed Web of Science ®Google Scholar
• Smith, R. C., D. Branellec, D. H. Gorski, K. Guo, H. Perlman, J. F. Dedieu, C. Pastore, A. Mahfoudi, P. Denefle, J. M. Isner, and Kenneth Walsh 1997. p21Cip1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11: 1674–1689.
   PubMed Web of Science ®Google Scholar
• Stein, G. H., and V. Dulic 1995. Origins of G1 arrest in senescent human fibroblasts. Bioessays 17: 537–543.
   PubMedGoogle Scholar
• Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. El-Houseini 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389–3396.
   PubMed Web of Science ®Google Scholar
• Stern, B., and P. Nurse 1996. A quantitative model for the cdc2 control of S phase and mitosis in fission yeast. Trends Genet. 12: 345–350.
   PubMed Web of Science ®Google Scholar
• Stillman, B. 1996. Cell cycle control of DNA replication. Science 274: 1659–1664.
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and T. Hunter 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67–74.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abbrogated by c-Myc. EMBO J. 15: 6595–6604.
   PubMed Web of Science ®Google Scholar
• Waldman, T., C. Lengauer, K. W. Kinzler, and B. Vogelstein 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713–716.
   PubMed Web of Science ®Google Scholar
• Won, K. A., and S. I. Reed 1996. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15: 4182–4193.
   PubMed Web of Science ®Google Scholar
• Wu, H., M. Wade, L. Krall, J. Grisham, Y. Xiong, and T. Van Dyke 1996. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev. 10: 245–260.
   PubMedGoogle Scholar
• Zeng, Y. X., and W. S. el-Deiry 1996. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557–1564.
   PubMed Web of Science ®Google Scholar
• Zhu, X., M. Ohtsubo, R. M. Enhmer, J. M. Roberts, and R. K. Assoian 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133: 391–403.
   PubMed Web of Science ®Google Scholar